Literature DB >> 11024382

Evolution of antimicrobial prophylaxis in cardiovascular surgery.

I Kriaras1, A Michalopoulos, M Turina, S Geroulanos.   

Abstract

OBJECTIVE: To examine the optimal duration of antibiotic prophylaxis in major cardiovascular surgery. MTHODSs: In the past 15 years, four prospective randomized, controlled studies, conducted by the same group of authors, compared seven prophylactic antimicrobial regimens in 2970 patients undergoing major cardiovascular surgery. In 1980/81, a 4-day cefazolin (CFZ) prophylaxis was compared with a 2-day cefuroxime (CFX) administration (n=566). In 1982/83, a 2-day CFX prophylaxis was compared with a two shot ceftriaxone (CRO) prophylaxis (n=512). In 1984/87, a 1-day CFZ prophylaxis was compared with a single shot prophylaxis of CRO (n=883). In 1994/1995, a 4 day combination of amoxicillin (AM) and netilmicin (NET) prophylaxis was compared with a single shot prophylaxis of CFX (n=1009).
RESULTS: Total infection rate varied between 4.5 and 5.7%, despite different antimicrobial regimen used and their varying duration. Wound infection rate was 1.1% (range 0.4-2.5%), sepsis rate was 0.8% (range 0.4-1.6%), pneumonia rate 2% (0.7-2.9%), urinary tract infection rate 0.4% (range 0-1.4%), and central venous catheter-related infection rate was 0.4% (0-1%). The 30-day mortality rate was 1.3% (range 0.4-2%). All these differences were not statistically significant.
CONCLUSIONS: A low infection rate (range 4.5-5.7%) occurred despite changes in duration of various prophylactic antibiotic regimen with cephalosporins of first, second or third generation. As a single shot prophylaxis could nowadays successfully be used in cardiovascular surgery, no postoperative antibiotics should be used, unless an intraoperative or a postoperative infection is documented or in presence of major perioperative complications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11024382     DOI: 10.1016/s1010-7940(00)00469-3

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

Review 1.  Bio-ecological control of perioperative and ITU morbidity.

Authors:  Stig Bengmark
Journal:  Langenbecks Arch Surg       Date:  2003-11-07       Impact factor: 3.445

2.  Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.

Authors:  Archana Asundi; Maggie Stanislawski; Payal Mehta; Anna E Baron; Hillary J Mull; P Michael Ho; Peter J Zimetbaum; Kalpana Gupta; Westyn Branch-Elliman
Journal:  Infect Control Hosp Epidemiol       Date:  2019-06-04       Impact factor: 3.254

3.  Blood concentrations of cefuroxime in cardiopulmonary bypass surgery.

Authors:  Daphne Bertholee; Peter G J ter Horst; Michel L Hijmering; Alexander J Spanjersberg; Wobbe Hospes; Bob Wilffert
Journal:  Int J Clin Pharm       Date:  2013-06-21

4.  A meta-analysis of randomized, controlled trials assessing the prophylactic use of ceftriaxone. A study of wound, chest, and urinary infections.

Authors:  J C Woodfield; N Beshay; A M van Rij
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

5.  Ceftriaxone versus Other Antibiotics for Surgical Prophylaxis : A Meta-Analysis.

Authors:  Silvano Esposito; Silvana Noviello; Alessandro Vanasia; Paola Venturino
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.